DCF — UPPER VALLEY MEDICAL CENTER
Enterprise Value: $164.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$164.7M
Enterprise Value
$44.6M
PV of Cash Flows
$120.1M
PV of Terminal Value
$193.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $161.0M | $20.1M | 12.0% | $9.3M | $8.4M |
| Year 2 | $165.8M | $22.3M | 13.0% | $10.8M | $8.9M |
| Year 3 | $170.8M | $24.7M | 14.0% | $12.4M | $9.3M |
| Year 4 | $175.9M | $26.3M | 15.0% | $13.4M | $9.2M |
| Year 5 | $181.2M | $27.6M | 15.0% | $14.2M | $8.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $164.7M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$156.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.119794865295014
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5